Strong equity market performance and sustained investor appetite for AI and growth assets have sustained a robust U.S. IPO window through September 2026, with traditional offerings already exceeding $150 billion in proceeds for the year after SpaceX’s record June listing. Multiple mid-sized deals, including Oura’s planned $2.1 billion Nasdaq debut targeted for September 30 and ADARx Pharmaceuticals’ $350 million offering the prior week, continue to price, while confidential filings from Anthropic (targeting an October–November window) and others keep the pipeline active. Macro factors such as stable Treasury yields, elevated equity valuations, and reduced rate-cut uncertainty have lowered financing costs and encouraged late-stage private companies to accelerate listings before year-end. Key near-term catalysts include additional September and October pricing dates plus any regulatory or market reactions to the first mega-cap AI IPOs; several names have already signaled 2027 timing, underscoring that execution depends on sustained risk appetite and orderly absorption of supply.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedDiscord IPO probability collapses amid regulatory delays and market uncertainty
Discord plunges to 11%18%
Discord's expected IPO timeline shifted from early 2026 to mid-2027 due to SEC backlog and valuation concerns, causing market probabilities for a 2026 IPO to collapse and delaying its public debut.

































Beware of external links.
Beware of external links.
Frequently Asked Questions